Navigation Links
Blood Pressure Management Changed on Global Level with OSTAR's 3SI Interpretive Blood Pressure Algorithm
Date:10/24/2013

VANCOUVER, Wash., Oct. 24, 2013 /PRNewswire/ -- OSTAR Healthcare Technology, a Washington based medical device company, announced the North American launch of its revolutionary 3SI (3 simultaneous interpretations) Advanced Diagnostic Blood Pressure Algorithm. According to Doug Hemenway, President and CEO, "This North American launch of OSTAR 3SI algorithm and the following product releases to come, set the scene for a change in the overall role of blood pressure measurement globally. Furthermore they are vital steps in OSTAR's commitment to improving patient outcomes while avoiding unnecessary costs, in lockstep with current federal imperatives of Patient Privacy & Accountable Care Act (PPACA)."

(Logo: http://photos.prnewswire.com/prnh/20131024/PH03445LOGO

OSTAR – 3SI Interpretive Blood Pressure Monitoring Algorithm is the intelligent heart of the entire suite of OSTAR products, soon to be released. This unique algorithm interprets and evaluates the entire blood pressure measurement, providing meaningful early warning alerts of possible emerging Arrhythmias, Valvular and Coronary Arterial conditions to the clinical staff and patient. It is envisaged that this unique patented technology will change the relevance of the traditional automated blood pressure measurement, from that of an interesting trend measurement to a necessary useful predictive indicator of impending valvular and coronary heart disease or cardiac arrest. The 3SI algorithm will be available in all OSTAR products with a view to make it available for OEM arrangements if customer demand dictates.  The OSTAR 3SI interpretive algorithm is a natural progression, based on customer driven demand and the ongoing commitment to solving heart disease while presenting a cohesive predictive tool to the global clinical and patient world. "Over the long run this form of automated blood pressure algorithm could have an even greater impact than advent interpretive ECG algorithms or AED defibrillators," as stated by Paul A Markham President of V3 Healthcare Strategies. The result is reduced cost to healthcare systems and ultimately, to the American healthcare consumer.

About OSTAR Healthcare Technology

Based in Vancouver, Washington, OSTAR's Healthcare Technology's Suite of unique suite of Next Generation Patient Monitoring solutions brings forth superiority over conventional product's specification, quality and lower price; we challenge entire global hospitals blood pressure and oximeter measuring instruments. OSTAR services the academic teaching, acute, ambulatory and home care marketplace.

CONTACT INFORMATION:                                                            
Doug Hemenway
OSTAR Healthcare Technology
Email
www.ostar.us
Toll free: 800-654-2548       Fax: 360-883-6086

Read more news from OSTAR


'/>"/>
SOURCE OSTAR
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
2. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
3. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
4. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
5. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Glooko Launches the Glooko™ IR Adapter to Give ACCU-CHEK® Blood Glucose Meter Customers Access to the Glooko Logbook Solution
8. OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers
9. Spot On Sciences Awarded $1 Million DARPA Grant to Develop a Blood Sample Collection Device
10. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
11. Global Growth Factors (Blood And Tissue) Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/27/2016)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... second quarter ended March 26, 2016.  GAAP diluted ... and non-GAAP diluted EPS of $0.47 increased 14.6%.  ... reported basis, and 6.3% on a constant currency ... quarter, highlighted by 14.6% growth in non-GAAP EPS," ...
(Date:4/27/2016)... York , April 27, 2016 ... report titled, "Skincare Devices Market - Global Industry Analysis, ... According to the report, the global skincare devices market ... is anticipated to expand at a CAGR of 10.1% ... in 2023. Browse the full Skincare Devices Market ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart ... at its new location in the Exchange Furniture Mall at 112 Vilseck Road in ... 50-inch Samsung Smart TV. Plus attendees will have the opportunity to meet general dentists ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program ... to announce the launch of the GFCP Scoop in response to ... purpose of the GFCP Scoop site is to keep the gluten-free ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
Breaking Medicine News(10 mins):